Tampa General Hospital is the first in the Southeast to implement the MeMed BV host-response test in its emergency workflow, reporting a 33% reduction in cefepime use and 13% fewer hospitalizations, according to hospital-led research.
SeptiCyte RAPID demonstrated superior performance compared to procalcitonin and C-reactive protein in detecting sepsis among critically ill patients with hospital-acquired infections.
Sepsis is a life-threatening emergency caused by the body's extreme response to infection, requiring rapid diagnosis and treatment.
VolitionRx’s report demonstrated that the Nu.Q NETs sepsis test can predict patients who are at higher risk of deteriorating from sepsis.
Read More
A genetic signature in newborns can predict neonatal sepsis before symptoms appear, according to a new study by UBC and SFU researchers.
Read More
The QuickMIC system aims to improve sepsis care by enabling faster, more accurate antibiotic treatment decisions.
Read More
The $5 million contract will help develop a diagnostic system that delivers fast CBC results and improves early detection for sepsis.
Read More
A microfluidic chip-based method assesses sepsis severity by analyzing immune cell migration: a new approach to diagnosis and prognosis.
Read More
Abionic’s IVD CAPSULE PSP test gained FDA 510(k) clearance to rapidly detect sepsis, marking the company’s expansion into the U.S. market.
Read More
The Froedtert & Medical College of Wisconsin will screen patients in their network with the IntelliSep test for early sepsis detection.
Read More
Advances in AI and data science highlight innovative machine learning models that predict patient outcomes in multiple myeloma and sepsis.
Read More
Cytovale’s IntelliSep test helped support the sepsis management program for Our Lady of the Lake Regional Medical Center.
Read More
AI-based antimicrobial susceptibility test method promises rapid prediction of antimicrobial resistance using blood of sepsis patients.
Read More
A new study reveals that the nasal microbiota of ICU patients is more effective than gut microbiota in distinguishing sepsis from non-sepsis.
Read More
Bruker enhanced diagnostic solutions in microbial identification, antimicrobial susceptibility testing, early sepsis diagnostics, and more.
Read More
The Sepsis ImmunoScore is an AI/machine learning software as a medical device to guide rapid diagnosis and prediction of sepsis.Â
Read More
Find out how Cytovale’s IntelliSep test reduced cost of care and improved the efficiency of sepsis care for a large U.S. academic center.
Read More
This method is faster than blood cultures and is less likely to generate false positives compared to other DNA detection-based technologies.
Read More